Rabia Gurses Ozden - Feb 6, 2023 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Signature
/s/ Donald Notman, Attorney-in-Fact for Rabia Gurses Ozden
Stock symbol
OCUL
Transactions as of
Feb 6, 2023
Transactions value $
-$27,204
Form type
4
Date filed
2/8/2023, 06:33 PM
Previous filing
Feb 1, 2023
Next filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Sale -$27.2K -6.42K -5.95% $4.24 101K Feb 6, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2023. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.30, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.